0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Special Communication |

The Future of Research in Myasthenia

David P. Richman, MD1
[+] Author Affiliations
1Department of Neurology and Center for Neuroscience, University of California, Davis
JAMA Neurol. 2015;72(7):812-814. doi:10.1001/jamaneurol.2014.4740.
Text Size: A A A
Published online

Extract

This Special Communication reports on the latest research in myasthenia, which results from dysfunction of the neuromuscular synapse (ie, the neuromuscular junction), causing clinical “fatigue” that is defined as muscle weakness that worsens with muscle use and improves with rest.

Myasthenia results from dysfunction of the neuromuscular synapse (ie, the neuromuscular junction [NMJ]), causing clinical “fatigue,” which is defined as muscle weakness that worsens with muscle use and improves with rest. Electrodiagnostic testing demonstrates either decremental compound muscle action potentials in response to repetitive nerve stimulation at slow rates, generally 2 to 3 Hz, or increased synaptic jitter measured by single fiber electromyography. The majority of the myasthenic disorders result from dysfunction of the postsynaptic component of the NMJ, although involvement of either the synaptic cleft or the presynaptic motor nerve terminal can occasionally produce myasthenia.

Figures in this Article

First Page Preview

View Large
First page PDF preview

Figures

Place holder to copy figure label and caption
Figure.
Neuromuscular Junction

A, In a mature neuromuscular junction, motor axonal action potentials mediated by voltage-gated sodium and potassium channels (VGSC and VGKC, respectively) activate nerve terminal voltage-gated calcium channels (VGCCs). Calcium influx initiates the release of vesicular acetylcholine (ACh), which diffuses across the synaptic cleft and binds to the tightly packed ACh receptor (AChR) located on the peaks of the folds of the end-plate membrane. This process activates the receptor’s ligand-gated ion channel, leading to depolarization of the end-plate membrane. The depolarization activates the muscle VGSC, initiating a muscle action potential. Acetylcholine is then hydrolyzed by acetylcholinesterase (AChE) in the muscle basal lamina. B, In the developing neuromuscular junction, the motor axonal growth cone releases agrin into the intercellular matrix when it reaches a developing myotube. Agrin binds to lipoprotein receptor-related protein 4 (lrp4), and the complex binds to muscle-specific kinase (MuSK), resulting in activation of MuSK, which self-phosphorylates and then initiates a series of phosphorylations beginning with DOK7 and ending with rapsyn and the δ subunit of AChR. This process induces AChR clustering, the first step in the development of both the postsynaptic and presynaptic portions of the mature neuromuscular junction. The agrin-lrp4-MuSK interaction also appears to be required for maintenance of the mature synapse. P indicates phosphate.

Graphic Jump Location

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

1,206 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
Jobs
brightcove.createExperiences();